Johnson & Johnson Expects Vaccine Results Soon but Lags in Production

The U.S. needs J.&J.’s one-shot vaccine more than ever. But the company is behind on manufacturing promises made in its Operation Warp Speed contract.

View original article
Contributor: Carl Zimmer, Sharon LaFraniere and Noah Weiland